The International Clinical Research Organisation, Synexus Ltd from 2007 to 2014 and the CRO Simbec-Orion Group Research. He is a Trustee of The UK Stem Cell Foundation and a Director of Respiratory Innovation Wales Ltd. He has served on a number of other Boards as Director in the UK: NextPharma Ltd (contract manufacturer), ReNeuron plc from 1998 to 2012 (stem cell therapy), in the Netherlands: BAC BV (bioaffinity company), in Italy from 2007 to 2013: Sigma-Tau Finanziaria S.p.A (Pharmaceuticals), from 2010 to 2011 Tecnogen SpA in the USA: SciClone Inc (Biotech) and President of Sigma-Tau Pharmaceuticals Inc (Rare Diseases) from 2012 to 2013. From 2000 until 2008, he was Vice Chair of King's College London Council. He holds honorary degrees/fellowships/gold medals from seven universities, was awarded an Honorary Fellowship of the Royal College of Physicians and The British Pharmacological Society and was elected to the French Academie Nationale de Pharmacie. He is a member of the Industrial Advisory Board and the Vice Chancellor's Advisory Committee at the University of Surrey; the Advisory Board to the School of Management at Swansea University; a member of the Advisory Board of the Academy of Pharmaceutical Sciences (APS); and formerly a Senator for the European Federation for Pharmaceutical Sciences (EUFEPS). He has published more than 150 papers (see further reading below) in learned and professional journals and is on the editorial board of a number of learned journals. The latter are Drug Development Communications (Marcel Dekker) from 1973; the International Journal of Pharmaceutical Technology and Product Manufacture (Childwall University Press) from 1979; the International Journal of Pharmaceutics (Elsevier) from 1984; Journal of Pharmacy and Pharmacology (Pharmaceutical Society of Great Britain) from 1985; Editions de Sante, Revue S.T. Pharma from 1986; "Advances in Pharmaceutical Sciences" Editor with Professor Ganderton, Academic Press from 1987; Journal of Drug Development from 1988; Editorial Advisory Board, "Drugs and the Pharmaceutical Sciences" from 1993; the Journal of Research in Pharmaceutical Economics from 1994. He is a frequent guest lecturer at international pharmaceutical conferences and seminars and has appeared regularly on radio and TV on pharmaceutical and medical issues. During the period 2003–2005, Jones was a Commissioner at the World Health Organization (WHO) on the Commission for Intellectual Property, Innovation and Public Health (CIPIH).